Amy Belt Raimundo is the Chief Business Officer for Evidation Health where she leads all commercial and business development activities. Previously, Amy focused on venture investing is the medical device sector as a Vice President at both Covidien Ventures and Advanced Technology Ventures (ATV). Before joining ATV, Amy was at Guidant Corporation (later Abbott Vascular) where she led the international launch of the Xience drug eluting stent and managed product lines in the US, Europe and Asia. She began her career as a Management Consultant for APM/CSC Healthcare, optimizing clinical guidelines and operations for major hospital systems. Amy is a Kauffman Venture Fellow and holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.
Amy Belt Raimundo
Deborah Kilpatrick, PhD
Deborah Kilpatrick is the CEO of Evidation Health, a digital health company held by GE Ventures, Asset Management, and Rock Health. Evidation Health helps health care purchasers demonstrate evidence-based value of digital health solutions through novel approaches to behavior analytics and health outcomes. Previously Deb was Chief Commercial Officer of genomic diagnostics company CardioDx, a past winner in the Wall Street Journal Technology Innovation Awards and the Edison Awards. Earlier in her career, Deb held multiple leadership roles at Guidant Corporation, including Director of R&D and Director of New Ventures. She serves on the Georgia Tech Advisory Board and is a Fellow of the American Institute of Medical and Biological Engineering. Deb has been previously named to FierceBiotech’s Top Women in Biotech as well as Silicon Valley Business Journal’s 100 Women of Influence. She holds B.S., M.S. and Ph.D. degrees in mechanical engineering with a bioengineering focus from Georgia Tech.
Laura is a commercial leader with experience in diagnostics, pharmaceuticals, and medical devices spanning cardiovascular, diabetes and oncology.
As founder of Options Consulting Group, she helps emerging companies with their go-to-market strategies to ensure a path to payment at the time of launch.
Prior to this she was the head marketing and commercial services at diaDexus, Inc.- makers of a test for heart attack risk assessment. As vp of marketing for Sequenta, she introduced the company to potential researchers – collaborations nearly tripled.
At Genoptix–a Novartis Co., she served as the head of marketing and led the company’s entry into the solid tumor space. While at Amylin, she led the direct to patient efforts for the launch of BYETTA®, a medicine for type 2 diabetes. Laura began her career in healthcare with Guidant (now Abbott Vascular).
She holds a BA from UC Santa Cruz and and MBA from UC Berkeley, Haas School of Business.
Bridget has over 16 years of US and International experience in product development and clinical trial management. She currently heads up Clinical and Regulatory for Element Science, a medical device company focused on developing a wearable therapeutic device for treatment of sudden cardiac death. Prior to this role, Bridget was the VP of Clin/Reg for Pulmonx and has held several management roles in R&D and Clinical at Abbott Vascular and Guidant. On the R&D side, Bridget played an integral role in the design and development of the XIENCE V drug-eluting stent program and the MitraClip percutaneous mitral valve repair system. On the clinical side, Bridget was based in Brussels as the Director for the EMEA Clinical and oversaw the international clinical operations for coronary and endovascular applications. Bridget holds a BS in Mechanical Engineering from The University of Texas at Austin, and an MS in Mechanical Engineering from Georgia Institute of Technology.
Jacqué Ashby is an Executive Assistant, Independent Event Manager, and Personal Chef. Prior to Aptus, she spent four years at FlowCardia/BPV, five years at Kyphon, and two years at Arthrocare, where her various roles included Executive Assistant, Sales Support Supervisor, and CSR. Through these various roles, a passion developed for Event Planning and Management of all meeting types, domestically and internationally: industry tradeshows, board meetings, sales meetings, incentive trips, physician advisory board, etc. Jacqué is multi-lingual, holds a BA in French w/ a German minor from SJSU, a Culinary Arts Diploma from PCI, now FCI California, and is the recipient of the Bert Cutino Award for Culinary Excellence.
Jennifer T. Beedon
Jennifer Beedon is an interim executive and advisor to medical device companies. She partners with early stage CEOs and entrepreneurs to develop business plans to attract investment, and build market entry strategies. Senior leaders at Fortune 500 companies seek Jennifer’s expertise to evaluate compelling business opportunities, providing the foundation for strategic investment.
Jennifer’s insight stems from 20 years of operational, consulting, and general management experience. Prior to founding her own firm, Jennifer held domestic and international leadership roles in business development, marketing and manufacturing operations at Guidant Corporation (now Abbott Vascular) and 3M. Jennifer is a co-founder of MedtechWomen. She holds an MBA from Harvard Business School and a BS in chemical engineering from the University of Michigan.
Jessica Hudak, a registered patent agent, specializes in working with medical device start-up companies. Prior to founding Hudak Consulting Group LLC, Jessica served as Sr. Intellectual Property Manager for Baxano, Inc. (to be acquired by TranS1 Inc.) from 2008 to 2012. Prior to moving in house, Jessica worked as a patent agent for ShayGlenn LLP where her practice focused on medical device technology in multiple clinical areas for early-stage companies. Jessica was also Schox Patent Group’s Senior patent agent from 2004 to 2008. In September of 2006, Jessica graduated from the Stanford Biodesign Innovation Fellowship Program. Jessica currently serves as President of The Biodesign Alumni Association. Jessica received her MS in Biomechanical Engineering from Stanford University and her BS (magna cum laude) in Mechanical Engineering from the University of Michigan. As a mechanical engineer, Jessica interned for IDEO in 2006, Ethicon Endo-Surgery in 2004, and Stryker Instruments in 2003.
Natalie Shlafman is Vice President of Marketing at CardioDx, a cardiovascular genomic diagnostics company in Redwood City, CA. She joined the company in 2006 with responsibility to build out the company’s marketing capabilities. She leads product marketing, strategic and managed care marketing, communications, and market research. Prior to joining CardioDx, Natalie was in the Vascular Intervention Division of Guidant Corporation, where she worked in market development within the New Ventures unit and in product marketing within the Angioplasty Systems group. Natalie received her MBA from the Kellogg School of Management at Northwestern University. Prior to her MBA, Natalie worked in the high-tech industry and held product marketing roles at LogicTier and at SGI. Natalie received her BA in psychology with a business specialization from UCLA.
As founder of her own firm, Nicole works closely with companies and physicians to highlight innovation and leadership in the field of health care. Her targeted public relations and social media programs have brought life-transforming medical technologies to the forefront for millions of Americans. Based in Menlo Park, Calif., Nicole’s clients include Abbott, CardioKinetix, Ceterix Orthopaedics, Intersect ENT, NeoTract, Outset Medical, Pelvalon, Shockwave Medical. She was named a 2015 PR Executive of the Year by Business Intelligence Group.
Ms. Stimson has wide-ranging expertise in the medical device business in both large and start-up companies. She currently runs Marketing & Customer Service for Intersect ENT and has played a key role in building the company from its early stage to a commercial business. Prior to that, she served as Director of Marketing & Clinical Research for start-up heart valve company Mitralign. In her many years at Guidant, Ms. Stimson impacted top-priority products from the aspects of marketing, sales and R&D, effectively leading teams to design best-in-class products and launching them successfully in worldwide markets. Ms. Stimson holds a BS in biomedical engineering from Marquette University.
Tamara Elias, MD, recently joined Becton Dickinson as Head, Corporate Strategy and Business Development – Medical Segment. Prior to BD, Tamara spent over 8 years as a Partner at Essex Woodlands, a global healthcare-only growth equity firm, where she served on the Boards of Millennium Pharmacy Systems, a technology-based, long-term care pharmacy which sold to Pharmerica in 2014, BreatheAmerica which oversees outpatient clinics focused on the management of chronic airway diseases, Influence Health, the leading provider of online strategic patient engagement solutions for hospitals, and ATS Medical, which sold to Medtronic in 2010. Prior to Essex Woodlands, Tamara spent six years at McKinsey as a senior engagement manager and was a general surgery resident at Massachusetts General Hospital after receiving her MD at Johns Hopkins School of Medicine. Tamara is also a Kauffman Venture Fellow.
Virginia L. Giddings, PhD
Virginia Giddings heads Strategic R&D at Abbott Nutrition, with the responsibility for leading global R&D to deliver innovative science and technology into globally launched nutrition products. Her experience spans over 20 years in developing healthcare solutions, including in pharmaceuticals and medical devices. Previously at Abbott, she held roles leading Partner and Vascular Product Development, including XIENCE and ABSORB, which was named as R&D Magazine’s 2013 top 100 technologies. She had IP strategy roles with J&J ALZA, as well as consulting with Exponent. She started her career as an orthopaedic design engineer at the Hospital for Special Surgery. She currently serves on an Advisory Board for Cornell University. She is a registered patent agent and earned a BS and an ME in Mechanical Engineering from Cornell and a PhD in Orthopaedic Biomechanics from Stanford.
Amanda DePalma is the Vice President of Global Marketing at Endologix. Her responsibilities include global marketing, strategic planning, new product development, and brand management. Ms. DePalma has more than 19 years of medical device marketing and sales experience. Prior to joining us, Ms. DePalma held the position of Senior Director, Global Strategic Marketing at Edwards Lifesciences where she led the global strategy, business development and branding efforts for the Critical Care business unit. From 2005 to 2011 Ms. DePalma had positions of increasing responsibility at Kimberly-Clark Healthcare (now Halyard Health) including General Manager and Director of Global Strategic Marketing. Prior to that, Ms. DePalma held marketing positions at Guidant Corporation and Abbott Vascular. Ms. DePalma holds a B.S. in Marketing and an M.B.A. from the University of Florida Warrington College of Business.